This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International: COVID-19 Therapeutic Development & Production
April 27-28, 2021
Delivered in a 100% Virtual FormatBritish Summer Time (BST)

Anissa Boumlic-Courtade
Head of Global Vaccine & Plasma Segments, Bioprocessing at Merck


Dr. Anissa Boumlic-Courtade, Head of Global Vaccine & Plasma Segments, Bioprocessing, Merck, has been with this company for 10 years and has held different technical, marketing and business development roles during this time. Dr. Boumlic is currently focusing on developing go-to-market strategies and partnering with the industry to advance manufacturing. She’s also a member of the African Vaccine Manufacturing Initiative board and is renowned in the fields of biologicals, vaccines and gene therapy. Dr. Boumlic is a biotechnology engineer by training and holds a Ph.D. in Molecular and Cellular Biology combined with Biochemistry and Biotechnology from the Universities of Strasbourg and Thessaly.

Agenda Sessions

  • How New Platform Technologies will Reinvent Vaccine Manufacturing


Speakers at this event